Nanovesicular Mediation of the Gut-Brain Axis by Probiotics: Insights into Irritable Bowel Syndrome.

Radha Santonocito, Letizia Paladino, Alessandra Maria Vitale, Giuseppa D'Amico, Francesco Paolo Zummo, Paolo Pirrotta, Samuele Raccosta, Mauro Manno, Salvatore Accomando, Francesco D'Arpa, Francesco Carini, Rosario Barone, Francesca Rappa, Antonella Marino Gammazza, Fabio Bucchieri, Francesco Cappello, Celeste Caruso Bavisotto
Author Information
  1. Radha Santonocito: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy.
  2. Letizia Paladino: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID
  3. Alessandra Maria Vitale: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID
  4. Giuseppa D'Amico: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID
  5. Francesco Paolo Zummo: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID
  6. Paolo Pirrotta: Euro-Mediterranean Institute of Science and Technology (IEMEST), 90139 Palermo, Italy.
  7. Samuele Raccosta: Cell-Tech Hub, Institute of Biophysics, National Research Council of Italy, 90146 Palermo, Italy. ORCID
  8. Mauro Manno: Cell-Tech Hub, Institute of Biophysics, National Research Council of Italy, 90146 Palermo, Italy. ORCID
  9. Salvatore Accomando: Department of Health Promotion, Mother and Childcare, Internal Medicine and Medical Specialities "G D'Alessandro", PROMISE, University of Palermo, 90127 Palermo, Italy.
  10. Francesco D'Arpa: Department of Surgical, Oncological and Stomatological Disciplines, DICHIRONS, University of Palermo, 90127 Palermo, Italy.
  11. Francesco Carini: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy.
  12. Rosario Barone: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID
  13. Francesca Rappa: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID
  14. Antonella Marino Gammazza: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID
  15. Fabio Bucchieri: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy.
  16. Francesco Cappello: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID
  17. Celeste Caruso Bavisotto: Section of Human Anatomy, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy. ORCID

Abstract

BACKGROUND: Dysbiosis, influenced by poor diet or stress, is associated with various systemic diseases. Probiotic supplements are recognized for stabilizing gut microbiota and alleviating gastrointestinal issues, like irritable bowel syndrome (IBS). This study focused on the tryptophan pathways, which are important for the regulation of serotonin levels, and on host physiology and behavior regulation.
METHODS: Nanovesicles were isolated from the plasma of subjects with chronic diarrhea, both before and after 60 days of consuming a probiotic mix (Acronelle, Bromatech S.r.l., Milan, Italy). These nanovesicles were assessed for the presence of Tryptophan 2,3-dioxygenase 2 (TDO 2). Furthermore, the probiotics mix, in combination with HO, was used to treat HT29 cells to explore its cytoprotective and anti-stress effect.
RESULTS: In vivo, levels of TDO 2 in nanovesicles were enhanced in the blood after probiotic treatment, suggesting a role in the gut-brain axis. In the in vitro model, a typical HO-induced stress effect occurred, which the probiotics mix was able to recover, showing a cytoprotective effect. The probiotics mix treatment significantly reduced the heat shock protein 60 kDa levels and was able to preserve intestinal integrity and barrier function by restoring the expression and redistribution of tight junction proteins. Moreover, the probiotics mix increased the expression of TDO 2 and serotonin receptors.
CONCLUSIONS: This study provides evidence for the gut-brain axis mediation by nanovesicles, influencing central nervous system function.

Keywords

References

  1. Molecules. 2023 Jan 04;28(2): [PMID: 36677548]
  2. J Hum Nutr Diet. 2016 Oct;29(5):549-75 [PMID: 27272325]
  3. J Microbiol Biotechnol. 2023 Sep 28;33(9):1189-1196 [PMID: 37317628]
  4. Biology (Basel). 2023 Nov 01;12(11): [PMID: 37997993]
  5. Gastroenterology. 2019 Aug;157(2):507-521.e4 [PMID: 31071306]
  6. Brain Behav Immun. 2024 Jan;115:458-469 [PMID: 37924959]
  7. Front Immunol. 2021 Apr 22;12:673708 [PMID: 33968085]
  8. Front Microbiol. 2023 Dec 14;14:1323920 [PMID: 38163072]
  9. Nature. 2012 Sep 13;489(7415):220-30 [PMID: 22972295]
  10. Front Cell Dev Biol. 2021 Oct 22;9:733354 [PMID: 34751245]
  11. J Vis Exp. 2016 Nov 16;(117): [PMID: 27911359]
  12. Front Immunol. 2021 Jun 04;12:653208 [PMID: 34149693]
  13. Trends Immunol. 2018 Dec;39(12):1005-1020 [PMID: 30409559]
  14. Cell Mol Gastroenterol Hepatol. 2021;11(5):1463-1482 [PMID: 33610769]
  15. J Biol Chem. 2003 Apr 4;278(14):11916-24 [PMID: 12547828]
  16. World J Gastroenterol. 2014 Oct 21;20(39):14105-25 [PMID: 25339800]
  17. Appl Immunohistochem Mol Morphol. 2011 Dec;19(6):552-61 [PMID: 21441812]
  18. J Neurogastroenterol Motil. 2018 Jan 30;24(1):4-6 [PMID: 29291603]
  19. Lancet. 2020 Nov 21;396(10263):1664-1674 [PMID: 33049221]
  20. Life (Basel). 2022 Oct 19;12(10): [PMID: 36295079]
  21. Gut Microbes. 2024 Jan-Dec;16(1):2297864 [PMID: 38174551]
  22. Front Bioeng Biotechnol. 2022 Mar 14;10:836747 [PMID: 35360396]
  23. Eur J Cancer. 2020 Nov;139:119-134 [PMID: 32987253]
  24. Biomolecules. 2021 Dec 18;11(12): [PMID: 34944546]
  25. Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G851-9 [PMID: 20224007]
  26. Am J Pathol. 2018 May;188(5):1183-1194 [PMID: 29454749]
  27. Nat Med. 2016 Jun;22(6):598-605 [PMID: 27158904]
  28. Gut Microbes. 2022 Jan-Dec;14(1):2044723 [PMID: 35239463]
  29. Gut. 2019 Aug;68(8):1516-1526 [PMID: 31076401]
  30. Int J Mol Sci. 2020 Jan 19;21(2): [PMID: 31963896]
  31. Int J Mol Sci. 2021 Jul 16;22(14): [PMID: 34299233]
  32. Bioessays. 2017 Feb;39(2): [PMID: 28009057]
  33. Discov Med. 2023 Jun;35(176):312-320 [PMID: 37272098]
  34. Nat Rev Neurosci. 2012 Jul;13(7):465-77 [PMID: 22678511]
  35. Biochem J. 2002 Dec 1;368(Pt 2):471-81 [PMID: 12169098]
  36. Nutrients. 2023 Jun 29;15(13): [PMID: 37447285]
  37. Nutrients. 2023 Mar 27;15(7): [PMID: 37049461]
  38. Front Immunol. 2022 Jun 17;13:903526 [PMID: 35784338]
  39. J Agric Food Chem. 2023 Dec 6;71(48):18792-18801 [PMID: 37996788]
  40. Front Immunol. 2019 Sep 10;10:2113 [PMID: 31552046]
  41. Biology (Basel). 2023 Jan 28;12(2): [PMID: 36829474]
  42. Dig Liver Dis. 2023 Feb;55(2):187-207 [PMID: 36517261]
  43. J Extracell Vesicles. 2015 May 14;4:27066 [PMID: 25979354]
  44. Front Microbiol. 2023 Jul 03;14:1209067 [PMID: 37469436]
  45. Eur J Clin Nutr. 2022 Apr;76(4):489-501 [PMID: 34584224]
  46. Arthritis Rheum. 2009 Feb;60(2):380-9 [PMID: 19180475]
  47. Foods. 2023 Nov 27;12(23): [PMID: 38231756]
  48. FASEB J. 2021 Jul;35(7):e21701 [PMID: 34143529]
  49. Biomed Pharmacother. 2023 Apr;160:114295 [PMID: 36709600]
  50. Cell Death Dis. 2021 Apr 20;12(5):413 [PMID: 33879768]
  51. Dev Psychobiol. 2020 Sep;62(6):783-791 [PMID: 32072627]
  52. Nutr Res Pract. 2021 Aug;15(4):411-430 [PMID: 34349876]
  53. Microbiome Res Rep. 2022 Mar 5;1(2):11 [PMID: 38045643]
  54. Am J Physiol. 1997 Oct;273(4):G812-23 [PMID: 9357822]
  55. Scand J Gastroenterol. 2003 Sep;38(9):947-54 [PMID: 14531531]
  56. Front Physiol. 2011 Dec 07;2:94 [PMID: 22162969]
  57. Gut. 1991 Jan;32(1):73-9 [PMID: 1991641]
  58. Mol Med Rep. 2012 Apr;5(4):1027-32 [PMID: 22246134]
  59. J Dairy Sci. 2018 Dec;101(12):10792-10806 [PMID: 30268622]
  60. Front Cell Dev Biol. 2020 Nov 19;8:562812 [PMID: 33330446]
  61. Acta Biochim Pol. 2020 Dec 17;67(4):485-493 [PMID: 33332076]
  62. Int Rev Neurobiol. 2016;131:49-65 [PMID: 27793226]
  63. N Engl J Med. 2016 Dec 15;375(24):2369-2379 [PMID: 27974040]

Word Cloud

Created with Highcharts 10.0.0mix2probioticsstresslevelsnanovesiclesTDOeffectaxisgutmicrobiotastudytryptophanregulationserotonin60probioticcytoprotectivetreatmentgut-brainableheatshockfunctionexpressionproteinsBACKGROUND:DysbiosisinfluencedpoordietassociatedvarioussystemicdiseasesProbioticsupplementsrecognizedstabilizingalleviatinggastrointestinalissueslikeirritablebowelsyndromeIBSfocusedpathwaysimportanthostphysiologybehaviorMETHODS:NanovesiclesisolatedplasmasubjectschronicdiarrheadaysconsumingAcronelleBromatechSrlMilanItalyassessedpresenceTryptophan3-dioxygenaseFurthermorecombinationHOusedtreatHT29cellsexploreanti-stressRESULTS:vivoenhancedbloodsuggestingrolevitromodeltypicalHO-inducedoccurredrecovershowingsignificantlyreducedproteinkDapreserveintestinalintegritybarrierrestoringredistributiontightjunctionMoreoverincreasedreceptorsCONCLUSIONS:providesevidencemediationinfluencingcentralnervoussystemNanovesicularMediationGut-BrainAxisProbiotics:InsightsIrritableBowelSyndromeextracellularvesiclesgut–brainmetabolism

Similar Articles

Cited By